Agilent Showcases Mass Spec Solutions at ASMS 2019 Powerful solutions for today’s mass spectrometry laboratory SANTA CLARA, Calif., May 30, 2019 Agilent Technologies Inc. (NYSE: A) announced today cutting-edge lab technology solutions on show at the American Society for Mass Spectrometry Conference (ASMS) which is being held June 2 through June 6 in Atlanta, Georgia.... Read more
New State-of-the-Art Facility Increases Agilent’s Capacity to Produce Nucleic Acid-Based Therapeutics New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) today announced the opening of a production facility in Colorado that more than doubles its... Read more
Agilent Announces Unique Portfolio to Advance Immunotherapy Innovative solution provides cell-based tools for translational research and development SANTA CLARA, Calif., May 7, 2019 Agilent Technologies Inc. (NYSE: A) announces a unified portfolio of products for immunotherapy researchers. The innovative solution will showcase at Immunology 2019, the 103rd Annual Meeting of the American Association of Immunologists... Read more
Agilent and SomaLogic Sign Agreement for Supply of Custom Microarrays Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development SANTA CLARA, Calif., & BOULDER, Colo., April 30, 2019 Agilent Technologies Inc. (NYSE: A) and SomaLogic, Inc. (a privately held biotechnology... Read more
Agilent Receives an Expanded FDA Approval for its Companion Diagnostic in NSCLC PD-L1 IHC 22C3 pharmDx Can Now Be Used to Identify a Broader Range of NSCLC Patients for First-line Treatment With KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., April 16, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has... Read more
Agilent Introduces New Mass Spectrometry Solutions Increased capabilities for food testing, environmental screening, and metabolomics research with new systems and software workflows SANTA CLARA, Calif., April 15, 2019 Agilent Technologies, Inc. (NYSE: A) today announced a range of new products designed to deliver improved analytical and business outcomes for laboratories involved in a variety of... Read more
https://www.agilent.com/about/newsroom/presrel/2019/12apr-gp19008.html Read more
Agilent Introduces New System for RNA and DNA Quality Control Laboratories Instrument provides automated electrophoresis for labs with limited budgets SANTA CLARA, Calif., April 02, 2019 Agilent Technologies, Inc. (NYSE: A) announced today the shipping of a new instrument that offers laboratories a more affordable, low-throughput option for analyzing the quality of RNA and DNA... Read more
Agilent to Host National Academy of Engineering Business Meeting and Bioengineering Symposium Leading innovators will highlight their research in precision medicine and biological systems engineering SANTA CLARA, Calif., March 28, 2019 Agilent Technologies Inc. (NYSE: A) today announced that it will host the western regional conference of the National Academy of Engineering, along with a... Read more
Agilent Recognized as Great Place to Work in Europe Company receives awards from Great Place to Work Institute in both Germany and Spain SANTA CLARA, Calif., March 25, 2019 Agilent Technologies Inc. (NYSE:A) today announced that surveys conducted by the Great Place to Work Institute indicate that Agilent ranks among the best places to work... Read more